3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide

C22H22N4O2 — CID 55450942

IUPAC3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide
SMILESCCCn1c(=O)n(CCC(=O)Nc2ccc3ccccc3n2)c2ccccc21
InChIInChI=1S/C22H22N4O2/c1-2-14-25-18-9-5-6-10-19(18)26(22(25)28)15-13-21(27)24-20-12-11-16-7-3-4-8-17(16)23-20/h3-12H,2,13-15H2,1H3,(H,23,24,27)
InChIKeyLYCSPFPZSMWNDR-UHFFFAOYSA-N
MW374.44 g/mol
LogP3.79
Rot. Bonds6

About 3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide

3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide (PubChem CID 55450942) has the molecular formula C22H22N4O2 and a molecular weight of 374.44 g/mol. Its IUPAC name is 3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide.

Molecular Properties

Compound Name3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide
PubChem CID55450942
Molecular FormulaC22H22N4O2
Molecular Weight374.44 g/mol
Exact Mass374.17
IUPAC Name3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide
SMILESCCCn1c(=O)n(CCC(=O)Nc2ccc3ccccc3n2)c2ccccc21
InChIInChI=1S/C22H22N4O2/c1-2-14-25-18-9-5-6-10-19(18)26(22(25)28)15-13-21(27)24-20-12-11-16-7-3-4-8-17(16)23-20/h3-12H,2,13-15H2,1H3,(H,23,24,27)
InChIKeyLYCSPFPZSMWNDR-UHFFFAOYSA-N
XLogP3.79
TPSA68.92 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms28
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500374.44
LogP ≤ 53.79
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[4-(carbamoylamino)phenyl]-3-(2-oxo-3-propylbenzimidazol-1-yl)propanamide
CID 33154220
N-(5-methyl-1,3,4-thiadiazol-2-yl)-3-(2-oxo-3-propylbenzimidazol-1-yl)propanamide
CID 17464567
3-(3-ethyl-2-oxobenzimidazol-1-yl)-N-pyridin-2-ylpropanamide
CID 18107170
3-(2-oxo-3-propylbenzimidazol-1-yl)-N-(4-oxoquinazolin-3-yl)propanamide
CID 134061353
N-[(1S)-1-(1H-benzimidazol-2-yl)ethyl]-3-(2-oxo-3-propylbenzimidazol-1-yl)propanamide
CID 18116505
ethyl 4-[3-(2-oxo-3-propylbenzimidazol-1-yl)propanoylamino]benzoate
CID 27007290
(Z)-N-quinolin-2-yloctadec-9-enamide
CID 145189390
2-fluoro-N'-[3-(2-oxo-3-propylbenzimidazol-1-yl)propanoyl]benzohydrazide
CID 27019412
N-(3-aminopropyl)-3-(2-oxo-3-propylbenzimidazol-1-yl)propanamide;hydrochloride
CID 119406011
N'-[3-(2-oxo-3-propylbenzimidazol-1-yl)propanoyl]cyclopropanecarbohydrazide
CID 27019386
N-[2-(difluoromethylsulfonyl)phenyl]-3-(2-oxo-3-propylbenzimidazol-1-yl)propanamide
CID 55446532
3-(2-oxo-3-propylbenzimidazol-1-yl)-N-[4-(phenylsulfamoyl)phenyl]propanamide
CID 24638182

Frequently Asked Questions

What is the IUPAC name of 3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide?
The IUPAC name of 3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide (CID 55450942) is 3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide.
What is the SMILES notation for 3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide?
The canonical SMILES for 3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide is CCCn1c(=O)n(CCC(=O)Nc2ccc3ccccc3n2)c2ccccc21.
What is the InChIKey of 3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide?
The InChIKey is LYCSPFPZSMWNDR-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H22N4O2/c1-2-14-25-18-9-5-6-10-19(18)26(22(25)28)15-13-21(27)24-20-12-11-16-7-3-4-8-17(16)23-20/h3-12H,2,13-15H2,1H3,(H,23,24,27).
What are the key properties of 3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide?
3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide has a molecular weight of 374.44 g/mol, XLogP of 3.79, 6 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(2-oxo-3-propylbenzimidazol-1-yl)-N-quinolin-2-ylpropanamide is sourced from PubChem (CID 55450942), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).